Evidence map›Paper›PMID 38462633›Full record

ReviewThe journal of headache and pain2024

The glymphatic system in migraine and other headaches.

Maria Grazia Vittorini, Aysenur Sahin, Antonin Trojan, Sevil Yusifli, Tamta Alashvili, Gonçalo V Bonifácio, Ketevan Paposhvili, Viktoria Tischler, Christian Lampl, Simona Sacco and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in The journal of headache and pain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  8. The evolving landscape of primary headache therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  9. Non-neuronal targets for migraine therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 6 countries.

Maria Grazia VittoriniDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Aysenur SahinFaculty of Medicine-Acibadem Mehmet, Ali Aydinlar University, Istanbul, Turkey.
Antonin TrojanDepartment of Neurology, Strakonice Hospital, Strakonice, Czechia.
Sevil YusifliFaculty of Medicine-Istanbul University, Istanbul, Turkey.
Tamta AlashviliDepartment of Internal Medicine, New Vision University Hospital, Tbilisi, Georgia.
Gonçalo V BonifácioDepartment of Neurology, Hospital de São Bernardo, Setúbal, Portugal.
Ketevan PaposhviliDepartment of Neurology, Tbilisi State Medical University, Tbilisi, Georgia.
Viktoria TischlerDepartment of Neurology, Konventhospital Barmherzige Brüder Linz, Linz, Austria.
Christian LamplDepartment of Neurology, Konventhospital Barmherzige Brüder Linz, Linz, Austria. christian.lampl@bblinz.at.
Simona SaccoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
School of Advanced Studies of the European Headache Federation (EHF-SAS)
Convent Hospital of the Brothers of Saint John of God · ATUniversity of L'Aquila · ITHospital de São Bernardo · PTIstanbul University · TRKent Hastanesi · TRStrakonice Hospital · CZTbilisi State Medical University · GE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glymphatic system is an emerging pathway of removing metabolic waste products and toxic solutes from the brain tissue. It is made of a network of perivascular spaces, filled in cerebrospinal and interstitial fluid, encompassing penetrating and pial vessels and communicating with the subarachnoid space. It is separated from vessels by the blood brain barrier and from brain tissue by the endfeet of the astrocytes rich in aquaporin 4, a membrane protein which controls the water flow along the perivascular space. Animal models and magnetic resonance (MR) studies allowed to characterize the glymphatic system function and determine how its impairment could lead to numerous neurological disorders (e.g. Alzheimer's disease, stroke, sleep disturbances, migraine, idiopathic normal pressure hydrocephalus). This review aims to summarize the role of the glymphatic system in the pathophysiology of migraine in order to provide new ways of approaching to this disease and to its therapy.

Indexed as

Glymphatic SystemMigraine DisordersNervous System DiseasesAnimalsBlood-Brain BarrierBrainHeadacheCerebrospinal fluidCGRPCortical spreading depressionDTI-ALPSGlymphatic systemHeadacheMigraineNeurological disordersPerivascular space

Identifiers

PMID38462633
PMCPMC10926631
OpenAlexW4392756595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.